Biosimilaires: qu’en pense le prescripteur ?

Autor: M. S. Aapro

Publikováno v: Oncologie. 13:234-238

Until recently the prescriber had to deal with generics, considered to be simple molecules which are easy to copy. But as discussed in this paper, the biodisponibility of generics remains a source of uncertainty. And now arrive biosimilars, limited f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::efd5d6f9c0d6945037ee16ce839bcb8e
https://doi.org/10.1007/s10269-011-2015-y

A randomized double-blind trial to compare the clinical efficacyof granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis

Autor: Cristiana Sessa, B. Thuerlimann, C. de Pree, M. S. Aapro, Rudolf Maibach, Jürg Bernhard

Publikováno v: Annals of Oncology. 14:291-297

Background The prophylactic use of 5-HT3 receptor antagonists (setrons), after the first 24 h (acute phase) of exposure to emetic chemotherapy, to decrease the incidence of ‘delayed phase’ emesis increases costs. We designed a study to evaluate t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a23fc927c72ac1177120947fecac63
https://doi.org/10.1093/annonc/mdg075

Éviter et gérer l’urgence fébrile en oncologie

Autor: M. Deblock, M. S. Aapro

Publikováno v: Annales françaises de médecine d'urgence. 1:229-231

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3e87247ac836b659ff453c67ffa942f2
https://doi.org/10.1007/s13341-011-0086-4

Docetaxel (Taxotere®)-cisplatin (TC): An effective drug combination in gastric carcinoma

Autor: Nicola Fazio, G. Martinelli, Rudolf Maibach, R. Morant, Cavalli Franco, Richard Herrmann, M. S. Aapro, Pierre Alberto, Monica Castiglione, Arnaud Roth, Markus Borner, A. Goldhirsch, Olivia Pagani, Hanspeter Honegger

Publikováno v: Roth, A. D.; Maibach, R.; Martinelli, G.; Fazio, N.; Aapro, M. S.; Pagani, O.; Morant, R.; Borner, M. M.; Herrmann, R.; Honegger, H.; Cavalli, F.; Alberto, P.; Castiglione, M.; Goldhirsch, A. (2000). Docetaxel (Taxotere®)-cisplatin (TC): An effective drug combination in gastric carcinoma. Annals of oncology, 11(3), pp. 301-306. Oxford University Press 10.1023/A:1008342013224

Purpose: A multi-centric trial was performed to explore the clinical activity, in terms of response and toxicity (primary objectives), duration of response and survival (secondary objectives), of docetaxel with cisplatin in advanced gastric cancer (A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f15a11c9196ec5106cb20a29f03b8485
https://doi.org/10.1023/a:1008342013224

Screening for cancer, 1995: An update

Autor: Bernadette Mermillod, C. de Pree, M. S. Aapro, R. O. Mirimanoff, Anastase Spiliopoulos, Youri Popowski, Pierre Alberto

Publikováno v: Annals of Oncology. 6:551-557

Summary Background This study was designed to evaluate the feasibility of a neo-adjuvant combined chemo-radiotherapy in patients with localized squamous cell carcinoma of the esophagus. Patients and methods Forty-two patients with squamous cell carci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::945816e1f4e87c3a5c14d4f3dbaf25a4
https://doi.org/10.1093/oxfordjournals.annonc.a059243